Kyverna Therapeutics, Inc. (KYTX) total debt

Total debt · fiscal 2025
$29.03M

Kyverna Therapeutics, Inc. (KYTX) carried total debt of $29.03M at the end of fiscal 2025 (December 31, 2025). That is 252.2% higher than the $8.24M of fiscal 2024. Figures as of 18 Nov 2026, 10:34 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
$29.03M
Change on fiscal 2024
+252.2%
Highest on record
$29.03Mfiscal 2025
Lowest on record
$8.24Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kyverna Therapeutics, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $29.03M in fiscal 2025 and the lowest $8.24M in fiscal 2024.

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Kyverna Therapeutics, Inc. total debt, year by year

Kyverna Therapeutics, Inc. (KYTX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$29.03M 252.2% up0.1×
2024$8.24M 9.2% down0.0×
2023$9.08M 14.1% down—
2022$10.56M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on KYTX

Kyverna Therapeutics, Inc., figure by figure

Kyverna Therapeutics, Inc. (KYTX) overview: price, valuation and scorecard

Kyverna Therapeutics, Inc. total debt: questions and answers

How much debt does Kyverna Therapeutics, Inc. have?

Kyverna Therapeutics, Inc. (KYTX) carried total debt of $29.03M at the end of fiscal 2025 (December 31, 2025). That is 252.2% higher than the $8.24M of fiscal 2024.

What are the highest and lowest total debt figures on record for Kyverna Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $29.03M in fiscal 2025 and the lowest $8.24M in fiscal 2024.

How does Kyverna Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

How is Kyverna Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Kyverna Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kyverna Therapeutics, Inc. (KYTX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/KYTX/total-debt

Underlying data: Yahoo Finance.